Company Filing History:
Years Active: 2018-2022
Title: Myung Kwan Han: Innovator in Sepsis Treatment
Introduction
Myung Kwan Han is a notable inventor based in Jeonju-si, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of sepsis and septic shock. With a total of 2 patents, his work focuses on innovative solutions that aim to improve patient outcomes.
Latest Patents
Myung Kwan Han's latest patents include a composition containing an inducer of SIRT1 expression for preventing or treating sepsis or septic shock. This invention highlights the potential of SIRT1 (silent mating type information regulation 2 homolog) to reduce mortality associated with sepsis by modulating inflammatory responses. The inducer of SIRT1 expression can significantly lower pro-inflammatory cytokines while increasing anti-inflammatory cytokines, making it a valuable tool in the fight against sepsis.
Career Highlights
Myung Kwan Han is currently associated with Stemdr Inc., where he continues to develop innovative medical solutions. His research has garnered attention for its potential to transform treatment protocols for sepsis, a condition that poses a significant risk to patients worldwide.
Collaborations
Myung Kwan Han collaborates with talented individuals such as Chae Hwa Yoo and Eun Kyung Song. Their combined expertise contributes to the advancement of research and development in the medical field.
Conclusion
Myung Kwan Han's contributions to the treatment of sepsis through his innovative patents demonstrate his commitment to improving healthcare outcomes. His work is a testament to the impact of research and innovation in addressing critical medical challenges.